# The Use of Oracea and Epiduo Forte in Severe Acne Patients

> **NCT03457636** · PHASE4 · COMPLETED · sponsor: **Derm Research, PLLC** · enrollment: 22 (actual)

## Conditions studied

- Acne

## Interventions

- **DRUG:** Doxycycline Anhydrous 40 MG
- **DRUG:** Adapalene/Benzoyl Peroxide Gel 0.3-2.5%

## Key facts

- **NCT ID:** NCT03457636
- **Lead sponsor:** Derm Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-19
- **Primary completion:** 2018-11-01
- **Final completion:** 2019-01-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03457636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03457636, "The Use of Oracea and Epiduo Forte in Severe Acne Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03457636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*